Browse Category

Johnson & Johnson News 2 November 2025 - 12 December 2025

Johnson & Johnson (JNJ) Stock News Today, Forecasts and Analyst Targets (Dec. 12, 2025)

Published: December 12, 2025 Johnson & Johnson stock (NYSE: JNJ) is ending the week in the spotlight as shares hover near record territory, helped by a steady stream of analyst target updates, fresh late-stage clinical data disclosures, and a clearer

12 December 2025

Johnson & Johnson (JNJ) Stock After the Bell on December 10, 2025 – And What to Watch Before the December 11 Open

Johnson & Johnson stock is back in the market’s spotlight. After a powerful run in 2025, JNJ is now trading just under record highs as investors juggle two very different narratives: blockbuster oncology and immunology growth on one side, and

11 December 2025

Earnings Reports · Investment Strategies · Johnson & Johnson · Market Analysis · NYSE:JNJ · Stock Market

J&J Makes Bold Move: Orthopedics Spin-Off (“DePuy Synthes”) Announced – 2025 Forecast Raised

Johnson & Johnson Stock Primed for Rally? Premarket Insights for Nov 3, 2025

Earnings & Guidance Lift Hopes Johnson & Johnson’s Q3 report and guidance boost have underpinned recent optimism. Excluding currency effects, total sales rose 6.8% to $23.99B, with key drugs like Darzalex ($3.67B) and its autoimmune blockbusters driving growth ts2.tech reuters.com.

2 November 2025

Financial News · Investing · Johnson & Johnson · Premarket Analysis · Stock Market

Go toTop